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Background: During 2009/10 a major measles epidemic caused by genotype B3 occurred in South Africa. Measles
inclusion body encephalitis (MIBE) was diagnosed in a number of highly immuno-compromised HIV patients. The
diagnosis was based on typical clinical and MRI findings and positive measles virus PCR in brain or CSF.
To characterize the brain virus, nucleoprotein, matrix, fusion and haemagglutinin genes from 4 cases was compared
with virus from acutely infected patients.
Methods: cDNA was synthesized using random primers and viral genes were amplified by nested RT-PCR. PCR
products were sequenced in the forward and reverse direction and a contig of each gene was created. Sequences
were aligned with reference sequences from GenBank and other local sequences.
Results: Brain virus was very similar to the South African epidemic virus. Features characteristic of persistent
measles virus in the brain were absent. Mutation frequency in brain virus was similar to epidemic virus and had the
same substitution preference (U to C and C to U). The virus of 2 patients had the same L454W mutation in the
fusion protein.
Conclusion: The brain virus was very similar to the epidemic strain. The relatively few mutations probably reflect
the short time from infection to brain disease in these highly immuno-compromised patients.
Keywords: Measles inclusion body encephalitis, MIBE, Subacute measles encephalitis, Neuro-virulence, Mutation,
Immuno-compromised, Human immunodeficiency virusBackground
During 2009 and 2010 a widespread measles virus epi-
demic occurred in South Africa. More than 18 000 cases
were laboratory confirmed. The majority of infections
were in young people. One third were infants less than
one year of age and the rest were between one and 40
years [1]. This outbreak occurred in a population with a
very high HIV prevalence. South Africa has an average
HIV prevalence of 30.2% in women attending antenatal
clinics and an estimated prevalence in all adult South
Africans of 17.9% (15–49 years) [2]. During the course of
this epidemic, a high rate of complications was seen in
HIV-infected subjects and a number of patients developed* Correspondence: Diana.Hardie@uct.ac.za
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reproduction in any medium, provided the ora distinct neurological syndrome, confirmed to be measles
inclusion body encephalitis (MIBE). The first 8 confirmed
cases [3] were all young (under 40 years), HIV-infected
and had low CD4 counts. Most gave a history of measles
in the preceding weeks. MIBE was not identified in any
HIV- negative individuals during this epidemic.
There are three neurological complications following
acute measles infection. Within 2 weeks of the onset of the
rash, an acute demyelinating encephalomyelitis (ADEM)
may develop. This is an auto-immune phenomenon as
measles virus is not present in the brain [4]. Measles inclu-
sion body encephalitis, also termed subacute measles en-
cephalitis, typically occurs one to nine months after acute
measles infection in highly immuno-compromised individ-
uals, either as a result of HIV infection or haematological
malignancies [5,6]. Sub-acute sclerosing pan encephalitis
(SSPE) typically occurs in apparently immuno-competentLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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latent period and the virus from brain tissue is highly de-
fective. In both MIBE and SSPE the brain is the site of on-
going measles pathology. The virus evades immune de-
fenses by spreading from cell to cell within the brain
[7]. Key viral structural genes (matrix, fusion and haem-
agglutinin) are highly mutated, rendering the proteins
nonfunctional [8]. We were interested to investigate
the virus from brains of local MIBE cases to determine
whether the virus was similarly defective and whether
there were any common features which could explain
the pathogenesis of the condition. Accordingly, the nu-
cleoprotein (N), matrix (M), fusion (F) and haemagglu-
tinin (H) genes from 4 MIBE cases (see Table 1 for
clinical details) were compared with virus from patients
acutely infected during this epidemic.
Results
Complete sequence data for N, M, F and H genes was
obtained for brain virus of 2 patients (1 and 3) and epi-
demic virus from 6 patients (GenBank accession num-
bers KC305651-KC305689]. Incomplete sequence data
was obtained from brain virus of a further 2 patients (2
and 4). Partial sequence was due to limited clinical ma-
terial available for PCR amplification. For patient 4,
most of the H gene sequence was available (nucleotides
246–1874) and partial sequence for the F gene (nucleo-
tide 1–1690) and for patient 2, the complete N, M and F
genes were sequenced.
Phylogenetic analysis of epidemic virus
Phylogenetic analysis of the nucleoprotein and haem-
agglutinin genes confirmed that the South African epi-
demic in 2009/10 was caused by genotype B3. (Figures 1,
2) The South African sequences formed a distinct cluster
within genotype B3.1 and this held true in phylogenetic
trees of the F and M genes as well (Figure 3A and B).
Brain and acute virus sequences clustered closely to-
gether on all phylogenetic trees (Figures 1, 2 and 3).
BLAST analysis of the South African consensus M and
F genes showed that the epidemic virus was most closely
related to JN635408, a 2005 isolate from New Jersey, USA.Table 1 Details of study patients
Patient 1 Patient 2
Age 26 14
Sex F M
CD4 count 65 1
Acute measles prior to disease onset 3 months Unknown (n
Sample type analysed Brain CSF
Vaccine history Unknown Received me
*Schwartz strain.The consensus N and H genes were more closely related
to 1998 measles virus isolates from Nigeria (AJ232781 and
AJ 239171). A concatenated phylogenetic tree of the full
N, M, F and H genes confirmed a close relationship of the
South African measles viruses to B3 viruses from North
Africa (Figure 4).
There was very little sequence variation in the epidemic
virus. A total of 24 polymorphisms were present in the six
acutely infected patients over the 6.728 Kb region se-
quenced (giving a mutation frequency of 0.56 per 1000
nucleotides).
Sequence analysis of brain virus
Sequences from the acute epidemic virus were aligned and
used to create a South African consensus sequence to
which the brain virus of patients 2, 3 and 4 were compared.
The brain virus from patient 1 was compared with her
own acute blood virus from 3 months earlier. In all pa-
tients the brain virus was very similar to the epidemic
virus. Typical features of measles virus of SSPE/MIBE cases
were not present, namely hyper mutation of the matrix
and fusion proteins or truncation of C terminal end of fu-
sion protein gene [9]. Each MIBE patient had a unique pat-
tern of mutations in one or more of the N, M, F and H
genes (Table 2). In total (for all genes sequenced) there
were 18 polymorphisms present in brain virus relative to
the South African consensus sequence, (Table 2).
U to C and C to U mutations were the most common
mutations present in the epidemic virus and were also the
most frequent in the brain virus. The calculated mutation
frequency in brain virus was 0.87 per 1000 nucleotides.
This was not significantly different from the mutation fre-
quency of the epidemic virus which was 0.56 per 1000 nu-
cleotides (p=0.19). Interestingly, of the 10 substitutions
that occurred in coding regions in the brain virus, 8 were
non-synonymous. The most variable region was the non
coding region of the fusion gene.
Patients 1 and 3 had an identical U to G mutation at
position 1944 in the F gene which gave rise to a L454W
substitution in the fusion protein. Of note, the L454W
substitution was not present in the blood virus of patient 1
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Figure 1 (See legend on next page.)
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Figure 1 Phylogenetic tree generated by neighbour-joining analysis of the 3′ hypervariable region of the nucleoprotein gene of measles
virus from patients with acute measles infection and MIBE during the measles epidemic of 2009–2010 in South Africa. Reference sequences
of other measles virus genotypes were retrieved from the NCBI GenBank database and are indicated by accession numbers. Bootstrap values greater
than 75% are indicated at the nodes of the tree. The branch lengths are proportional to the evolutionary distances as shown on the scale.
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The measles virus outbreak in South Africa was due to
genotype B3 a known African genotype. It was probably
introduced into South Africa from the north where on-
going circulation of measles virus of this genotype has
been documented in various African countries for many
years [10,11]. Infection spread widely in the South African
population due to poor herd immunity. Analysis of mea-
sles virus sequences from acutely infected individuals
showed that there was a low level of genetic variability in
the epidemic virus. This is typical of a single source intro-
duction which is followed by dissemination in a non im-
mune population [12,13].
While invasion of the brain during acute measles may
occur [14], MIBE is normally very rare. Most highly
immuno-compromised patients who had acute measles
in this epidemic did not develop MIBE. Clearly both
viral and host factors play a role in the disease process.
While much is known about the genetic characteristics
of SSPE virus, this is not the case for MIBE virus. We
were interested to sequence the brain virus in some of
these cases to determine its similarity to the epidemic
virus in order to try to gain insight into the pathogenesis
of this normally very rare condition.
On the whole, the brain virus was very similar to the
acute epidemic virus. This is in contrast to what is found
with SSPE [9,15] and also what has previously been
reported for MIBE [15]. Mutation rates were similar in
brain (0.87 per 1000 bases) to the epidemic virus (0.56 per
1000 bases). However, of the 10 substitutions that oc-
curred in the coding regions of genes from brain virus, 8
were non-synonymous (in comparison to only 4 of 22
from the epidemic virus). This could imply either that
some selection pressure was acting on the virus in the
brain or that a mutation generating process was operating.
Measles virus does not usually replicate extensively in
brain tissue and it is thought that key mutations may be
needed to confer a neuro-virulent phenotype [16,17]. Be-
cause of the many mutations found in SSPE virus, it
is difficult to determine which are responsible for neuro-
tropism and which are merely the consequence of
mutations accumulating in genes which are no longer
essential for virus replication in the brain. By studying
the fewer mutations in virus from MIBE brains it may
be possible to determine which were responsible for the
gain in neuro-tropism. In this study, most of the muta-
tions in the brain virus were different for each patientand targeted different genes. However, one point muta-
tion in the fusion protein, namely L454W was present in
2 patients (1 and 3). It is unlikely to have been a chance
polymorphism in some circulating virus because it was
not present in the acute measles sequence of patient 1.
Both leucine and tryptophan are neutral, non-polar
amino acids. However, this substitution is not favoured,
especially in a membrane protein, and the substitution
would be likely to change the properties of the protein
[18]. This substitution falls in the extra-cellular domain of
the fusion protein, adjacent to the heptad repeat B domain
(HRB). Ayata et al. [17] showed that a single substitution
(T461I) was responsible for neuro-virulence of an SSPE
strain in a hamster model. This region is thought to inter-
act with the as yet unknown measles virus receptor in the
brain and plays a role in the fusion process. The independ-
ent presence of this mutation in 2 patients is interesting.
There were remarkably few mutations in all four of the
genes sequenced from the brain virus. In measles virus
from persistently infected brain, both in humans as well as
in animal models, the nucleoprotein gene typically retains
its function as this protein is required to form intact
ribonuclear protein complexes to enable the virus to move
from cell to cell in the brain [7]. The matrix protein, on
the other hand, is usually highly mutated as this protein is
not needed for replication in the brain [19,20]. Perhaps
sufficient time had not elapsed for mutations to accumu-
late in this gene before the clinical presentation of MIBE
in our highly immuno-compromised patients. In 3 MIBE
patients who gave a history of acute measles, the median
time from acute infection to onset of neurological disease
was about 10 weeks. In all patients there was a rapid
neurological deterioration after presentation, which prob-
ably reflects the poor immune control of measles virus in
the brain.
In conclusion, it is probable that host factors were
largely responsible for driving the disease process. How-
ever, not all severely immuno-compromised HIV pa-
tients infected with measles developed MIBE. Viral
factors also must have played a role. Intriguingly the
brain virus was very similar to the epidemic virus and
did not show features previously reported to be charac-
teristic of MIBE. The mutation frequency was similar to
epidemic virus, but significantly these mutations were
more likely to be non-synonymous. A key finding was










































































































Figure 2 Phylogenetic tree generated by neighbour-joining analysis of the haemagglutinin gene of measles virus from patients with
acute measles infection and MIBE during the measles epidemic of 2009–2010 in South Africa. Reference sequences of other measles virus
genotypes were retrieved from the NCBI GenBank database and are indicated by accession numbers. Bootstrap values greater than 75% are
indicated at the nodes of the tree. The branch lengths are proportional to the evolutionary distances as shown on the scale.
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MIBE patients
Patients were identified as having MIBE based on typical
clinical and magnetic resonance (MRI) findings aspreviously described [3] and if measles virus was
detected by PCR in brain tissue or cerebrospinal fluid
(CSF). An in-house diagnostic nested RT-PCR assay was



































































































Figure 3 Phylogenetic trees generated by neighbour-joining analysis of the fusion (A) and matrix (B) genes of measles virus from
patients with acute measles infection and MIBE during the measles epidemic of 2009–2010 in South Africa. Reference sequences of
other measles virus genotypes were retrieved from the NCBI GenBank database and are indicated by accession numbers. Bootstrap values
greater than 75% are indicated at the nodes of the tree. The branch lengths are proportional to the evolutionary distances as shown on
the scale.
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CSF was available for study on 4 patients.
Patient 1 was a 27 year old woman who had a CD4
count of 65 at time of acute measles. MIBE onset oc-
curred 3 months after acute measles. Measles virus PCR
was positive on brain biopsy tissue. Brain virus was
compared with acute virus from blood taken 3 months
previously.
Patient 2 was a 14 year old boy with a CD4 count of 1
at time of neurological presentation. There was no his-
tory of a rash. This patient had received measles vaccine
(Schwartz strain) during a school mass vaccination cam-
paign some months before clinical presentation. Measles
virus PCR was positive in CSF.
Patient 3 was a 34 year old woman who developed typ-
ical MIBE symptoms 3 weeks after acute measles infec-
tion. Her CD4 count at presentation was 26. Measles virus
PCR was positive on post mortem brain tissue. Post
mortem histology confirmed MIBE.
Patient 4 was a 24 year old woman. MIBE developed
16 weeks after acute measles when the CD4 count was
11. Measles virus PCR was positive on post-mortem
brain tissue.Patients with acute measles
Measles virus amplified from a peripheral site such as
urine or blood from 5 acutely infected patients was used
to create a South African (SA) consensus sequence to
which the brain virus was compared.
In addition, measles virus from blood collected at the
time of acute measles was available from one patient
who subsequently developed MIBE (patient 1). The
brain virus of this patient was compared with her own
acute virus rather than the consensus sequence.Nucleic acid extraction
Total nucleic acid for measles virus screening was ini-
tially extracted using the Easymag automated extractor
(BioMerieux, Marcy l’Etoile, France) as per manufac-
turer’s instructions. Subsequently total nucleic acid
was extracted from the brain or CSF using the manual
Qiagen DNA mini kit with appropriate buffers for tis-
sue and CSF extraction as per manufacturer’s instruc-
tions (Qiagen, GmbH, Germany). Nucleic acid was





























































































Figure 4 (See legend on next page.)
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Figure 4 Phylogenetic tree generated by neighbour-joining analysis of concatentated nucleoprotein, matrix, fusion and
haemagglutitin genes of measles virus from patients with acute measles infection and MIBE during the measles epidemic of
2009–2010 in South Africa. Reference sequences of other measles virus genotypes were retrieved from the NCBI GenBank database and are
indicated by accession numbers. Bootstrap values greater than 75% are indicated at the nodes of the tree. The branch lengths are proportional to
the evolutionary distances as shown on the scale.
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RNA was converted into cDNA using the RevertAid First
Strand cDNA synthesis kit (Fermentas Life Sciences) and
random hexamers. Briefly 11 μl RNA was incubated with
1 μl random hexamers supplied with kit at 80°C for 3 mi-
nutes and then cooled to 37°C before the addition of 4 μl
5× reaction buffer, 1 μl Ribolock RNase inhibitor (20 U/
μl), 2 μl 10 mM dNTP mix and 1 μl RevertAid M-MuLV
reverse transcriptase (200 U/μl) in a final 20 μl reaction
volume. The mixture was incubated at 37°C for 90 min
and the reaction terminated by heating to 70°C for 5 mi-
nutes. cDNA was stored at −20°C until required.
The complete nucleoprotein (N), matrix (M), fusion
(F) and haemagglutinin (H) genes were amplified with
primers described by Tillieux et al. [21]. In cases where
there was no amplification after one round of PCR,
nested primers designed for this study were used.
(Additional file 1: Table S1).Table 2 Nucleotide and amino acid differences in the nucleop
genes between the South African measles consensus B3.1 seq
Gene Nucleotide position Nucleotide
SACon Pat1 Pat2 Pat3 Pat4
N 572 A A A G n/d
1623 U U U C n/d
M 328 U C U U n/d
388 U C U U n/d
399 A A U A n/d
F 105 C C U C C
127 C C G C C
162 C C U C C
203 C C C C U
323 G G G C G
331 C C A C C
461 G G C G G
766 U U U C U
1483 G G G G A
1592 A C A A A
1944 U G U G n/d
H 1362 C U n/d C
1742 C U n/d C C
SACon South African consensus sequence, Pat1 patient1, Pat2 patient2, Pat3 patient
from consensus. Nucleotides 105 to 461 in the fusion gene are non coding.Measles virus from a patient with acute measles was
used as the positive control for all the PCR assays. PCR
amplicons were generated using 6μl cDNA and Su-
pertherm Taq DNA polymerase (JMR Holdings, UK)
with the following PCR cycling conditions: an initial de-
naturation step of 3 min at 95°C, followed by 40 cycles
of amplification (15 sec at 94°C, 30 s at 50°C and 45 s
72°C) followed by 7 min at 72°C. The nested PCR was
performed using the same cycling conditions but with
an increase in the annealing temperature to 55°C and
3 μl outer product.
PCR products were electrophoresed through 2% agar-
ose gel and visualized by ethidium bromide staining and
UV illumination.
Sequencing and phylogenetic analysis
PCR products were sequenced directly in both directions
with primers used for PCR amplification. The BigDyerotein (N), matrix (M), fusion (F) and haemaglutinin (H)
uence and brain virus from 4 patients with MIBE
Amino acid position Amino acid
SACon Pat1 Pat2 Pat3 Pat4
174 I I I V n/d
524 L L L P n/d
99 I T I I n/d
119 L P L L n/d
123 T T S T n/d
337 M L M M M
454 L W W W n/d
448 R C R R R
3, Pat4 patient4, n/d not done. Bold font indicates nucleotide that varies
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Biosystems, Foster City CA, USA). Sequences were assem-
bled and aligned against the measles virus genotype B3 ref-
erence sequence (accession number HM439386) using
DNA Baser Sequence Assembler v3.5.0.
The 3′ hypervariable N and Hgenes were aligned with
reference sequences from GenBank using ClustalW and
neighbor-joining phylogenetic trees constructed using
MEGA version 5 with 1000 bootstrap re-samplings [22].
Similar neighbor-joining phylogenetic trees were also
constructed for the F and M genes as well as a con-
catenated tree of all genes sequenced.
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